A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).

被引:0
|
作者
Bin Riaz, Irbaz [1 ]
He, Huan [1 ]
Ryu, Alexander J. [1 ]
Siddiqi, Rabbia [2 ]
Naqvi, Syed Arsalan Ahmed [2 ]
Yao Yuan [1 ]
Husnain, Muhammad [3 ]
Maheswari, Deepa [1 ]
Sipra, Qurat Ul Ain Riaz [4 ]
Montori, Victor [1 ]
Joseph, Richard Wayne [5 ]
Liu Hongfang [1 ]
Wang Zhen [1 ]
Herasevich, Vitaly [1 ]
Singh, Parminder [6 ]
Ho, Thai Huu [7 ]
Bryce, Alan Haruo [6 ]
Pagliaro, Lance C. [1 ]
Murad, Hassan M. [1 ]
Costello, Brian Addis [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Dow Univ Hlth Sci, Karachi, Pakistan
[3] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[4] BUMC, Tucson, AZ USA
[5] Mayo Clin Hosp, Jacksonville, FL USA
[6] Mayo Clin, Phoenix, AZ USA
[7] Mayo Clin Arizona, Scottsdale, AZ USA
关键词
D O I
10.1200/JCO.2021.39.6_suppl.335
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
335
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma
    Bin Riaz, Irbaz
    He, Huan
    Ryu, Alexander J.
    Siddiqi, Rabbia
    Naqvi, Syed Arsalan Ahmed
    Yao, Yuan
    Husnain, Muhammad
    Narasimhulu, Deepa Maheswari
    Mathew, Jessey
    Sipra, Qurat Ul Ain Riaz
    Vandvik, Per Olav
    Joseph, Richard W.
    Liu, Hongfang
    Wang, Zhen
    Herasevich, Vitaly
    Singh, Parminder
    Hussain, Syed A.
    Ho, Thai H.
    Bryce, Alan H.
    Pagliaro, Lance C.
    Murad, Mohammad H.
    Costello, Brian A.
    EUROPEAN UROLOGY, 2021, 80 (06) : 712 - 723
  • [2] Optimal First-Line Treatment of Metastatic Renal-Cell Carcinoma: A Network Meta-Analysis
    Hahn, Andrew W.
    Hale, Peter
    Maughan, Benjamin L.
    Haaland, Benjamin
    Agarwal, Neeraj
    KIDNEY CANCER, 2018, 2 (02) : 115 - 121
  • [3] First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Hahn, Andrew W.
    Klaassen, Zachary
    Agarwal, Neeraj
    Haaland, Benjamin
    Esther, John
    Ye, Xiang Y.
    Wang, Xuechen
    Pal, Sumanta K.
    Wallis, Christopher J. D.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 708 - 715
  • [4] Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
    Cattrini, Carlo
    Messina, Carlo
    Airoldi, Chiara
    Buti, Sebastiano
    Roviello, Giandomenico
    Mennitto, Alessia
    Caffo, Orazio
    Gennari, Alessandra
    Bersanelli, Melissa
    THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
  • [5] Real-time evidence synthesis for first line (1L) treatment of metastatic renal cell carcinoma (mRCC): A living, interactive systematic review and Bayesian network metaanalysis.
    Naqvi, Syed Arsalan Ahmed
    He, Huan
    Siddiqi, Rabbia
    Khan, Nihal Ijaz
    Khakwani, Kaneez Zahra Rubab
    Ayaz, Ahsan
    Singh, Parminder
    Ho, Thai Huu
    Bryce, Alan Haruo
    McGregor, Bradley Alexander
    Xu, Wenxin
    Bin Riaz, Irbaz
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis
    Abidoye, Oluseyi
    Naqvi, Syed Arsalan Ahmed
    Faisal, Kunwer Sufyan
    Imran, Manal
    Khakwani, Kaneez Zahra Rubab
    Raina, Ammad
    Tripathi, Nikita
    Abdul-Muhsin, Haidar
    Costello, Brian Addis
    Singh, Parminder
    Bryce, Alan Haruo
    Riaz, Irbaz Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 412 - 412
  • [7] A systematic review and network meta-analysis of first-line treatment options in patients metastatic renal cell carcinoma
    Bin Riaz, Irbaz
    Ryu, Alexander J.
    Yao, Yuan
    Siddiqi, Rabbia
    Mathew, Jessey
    Sipra, Qurat Ul Ain Riaz
    Zahoor, Haris
    Wang, Zhen
    Murad, M. Hassan
    Pagliaro, Lance C.
    Costello, Brian Addis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis
    Rousseau, Benoit
    Kempf, Emmanuelle
    Desamericq, Gaelle
    Boissier, Emilie
    Chaubet-Houdu, Marie
    Joly, Charlotte
    Saldana, Carolina
    Boussion, Helene
    Neuzillet, Cindy
    Macquin-Mavier, Isabelle
    Oudard, Stephane
    Salomon, Laurent
    de la Taille, Alexandre
    Tournigand, Christophe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 107 : 44 - 53
  • [9] TOLERABILITY OF TARGETED AGENTS IN FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC)
    Su, Y.
    Shi, N.
    Landsman-Blumberg, P.
    Poehlein, C.
    Waxman, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 267 - 268
  • [10] TARGETED THERAPY IN FIRST-LINE THERAPY OF METASTATIC RENAL CELL CANCER (MRCC): SYSTEMATIC REVIEW WITH META-ANALYSIS (SRMA)
    Carcano, F. M.
    Santos, L. V.
    Tariki, M. S.
    Serrano, S. V.
    Sasse, A.
    Lima, J. P. S. N.
    ANNALS OF ONCOLOGY, 2010, 21 : 288 - 288